Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 1, 2015, Pages 24-35

  Janssen, Carola I F ^a   Zerbi, Valerio ^a   Mutsaers, Martina P C ^a   de Jong, Bas S W ^a   Wiesmann, Maximilian ^a   Arnoldussen, Ilse A C ^a   Geenen, Bram ^a   Heerschap, Arend ^a   Muskiet, Frits A J ^b   Jouni, Zeina E ^c   van Tol, Eric A F ^c   Gross, Gabriele ^c   Homberg, Judith R ^a   Berg, Brian M ^c   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Mead Johnson Nutritionals   (United States)

Author keywords

Animal models; Brain development; Cognition; Neurohistology; Omega 3 fatty acid supplementation; Phosphorus magnetic resonance imaging

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; LINOLENIC ACID; MEMBRANE PROTEIN; OMEGA 3 FATTY ACID;

ADULT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN HISTOLOGY; BRAIN METABOLISM; BRAIN REGION; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENCEPHALITIS; EXPLORATORY BEHAVIOR; FATTY ACID ANALYSIS; FEMALE; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; LIMIT OF QUANTITATION; MALE; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NEUROIMAGING; NONHUMAN; NUTRITIONAL DEFICIENCY; OPEN FIELD TEST; PERINATAL PERIOD; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREPULSE INHIBITION; PUBERTY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; ROTAROD TEST; SENSORIMOTOR INTEGRATION; SPATIAL LEARNING; SPATIAL MEMORY; STARTLE REFLEX; WILD TYPE; YOUNG ADULT; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; HIPPOCAMPUS; METABOLISM; MOTOR PERFORMANCE; NERVOUS SYSTEM DEVELOPMENT;

ANIMALIA; MUS;

8,11,14-EICOSATRIENOIC ACID; ALPHA-LINOLENIC ACID; ANIMALS; ARACHIDONIC ACID; COGNITION; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; GUANYLATE KINASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MOTOR SKILLS; NEUROGENESIS; SYNAPTOPHYSIN;

EID: 84926251834     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.08.002     Document Type: Article

References (88)

1. Muskiet F.A.J. Pathophysiology and evolutionary aspects of dietary fats and long-chain polyunsaturated fatty acids across the life cycle. Fat Detection: Taste, Texture, and Post Ingestive Effects 2010, CRC Press, Boca Raton (FL). J.P. Montmayeur, J. le Coutre (Eds.).
2. Carlson S.J., Fallon E.M., Kalish B.T., Gura K.M., Puder M. The role of the omega-3 fatty acid DHA in the human life cycle. JPEN J Parenter Enteral Nutr 2013, 37:15-22.
3. Simopoulos A.P. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol 2011, 44:203-215.
4. Storck Lindholm E., Strandvik B., Altman D., Moller A., Palme K.C. Different fatty acid pattern in breast milk of obese compared to normal-weight mothers. Prostaglandins Leukot Essent Fatty Acids 2013, 88:211-217.
5. Ailhaud G., Massiera F., Weill P., Legrand P., Alessandri J.M., Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006, 45:203-236.
6. Makrides M., Neumann M.A., Gibson R.A. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996, 50:352-357.
7. Garcia C., Millet V., Coste T.C., Mimoun M., Ridet A., Antona C., et al. French mothers' milk deficient in DHA contains phospholipid species of potential interest for infant development. J Pediatr Gastroenterol Nutr 2011, 53:206-212.
8. Brenna J.T. Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life. Matern Child Nutr 2011, 7(Suppl 2):59-79.
9. Gibson R.A., Muhlhausler B., Makrides M. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2years of life. Matern Child Nutr 2011, 7(Suppl 2):17-26.
10. Innis S.M. Omega-3 Fatty acids and neural development to 2years of age: do we know enough for dietary recommendations?. J Pediatr Gastroenterol Nutr 2009, 48(Suppl 1):S16-S24.
11. Fedorova I., Alvheim A.R., Hussein N., Salem N. Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency. Behav Neurosci 2009, 123:1218-1225.
12. Fedorova I., Salem N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids 2006, 75:271-289.
13. McNamara R.K., Able J., Jandacek R., Rider T., Tso P., Lindquist D.M. Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo 1H-MRS study. J Lipid Res 2009, 50:405-411.
14. Moriguchi T., Salem N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 2003, 87:297-309.
15. Lyall K., Munger K.L., O'Reilly E.J., Santangelo S.L., Ascherio A. Maternal dietary fat intake in association with autism spectrum disorders. Am J Epidemiol 2013, 178:209-220.
16. Yui K., Koshiba M., Nakamura S., Kobayashi Y. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol 2012, 32:200-206.
17. Gustafsson P.A., Birberg-Thornberg U., Duchen K., Landgren M., Malmberg K., Pelling H., et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr 2010, 99:1540-1549.
18. Perera H., Jeewandara K.C., Seneviratne S., Guruge C. Combined omega3 and omega6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. J Child Neurol 2012, 27:747-753.
19. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006, 75:259-269.
20. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 2004, 152:49-57.
21. Umezawa M., Ohta A., Tojo H., Yagi H., Hosokawa M., Takeda T. Dietary alpha-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM). Brain Res 1995, 669:225-233.
22. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., et al. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009, 111:510-521.
23. Dyall S.C., Michael G.J., Michael-Titus A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res 2010, 88:2091-2102.
24. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromolecular Med 2008, 10:219-235.
25. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 2004, 101:10931-10936.
26. Sidhu V.K., Huang B.X., Kim H.Y. Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and O-16/O-18 labeling. J Proteome Res 2011, 10:5472-5480.
27. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008, 47:147-155.
28. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233:674-688.
29. Tassoni D., Kaur G., Weisinger R.S., Sinclair A.J. The role of eicosanoids in the brain. Asia Pac J Clin Nutr 2008, 17:220-228.
30. Tapiero H., Ba G.N., Couvreur P., Tew K.D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 2002, 56:215-222.
31. Fang P.C., Kuo H.K., Huang C.B., Ko T.Y., Chen C.C., Chung M.Y. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. Chang Gung Med J 2005, 28:708-715.
32. Fewtrell M.S., Abbott R.A., Kennedy K., Singhal A., Morley R., Caine E., et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004, 144:471-479.
33. Henriksen C., Haugholt K., Lindgren M., Aurvag A.K., Ronnestad A., Gronn M., et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008, 121:1137-1145.
34. Isaacs E.B., Ross S., Kennedy K., Weaver L.T., Lucas A., Fewtrell M.S. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011, 128:e890-e898.
35. Makrides M., Gibson R.A., McPhee A.J., Yelland L., Quinlivan J., Ryan P., et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010, 304:1675-1683.
36. Westerberg A.C., Schei R., Henriksen C., Smith L., Veierod M.B., Drevon C.A., et al. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 2011, 100:47-52.
37. Birch E.E., Carlson S.E., Hoffman D.R., Fitzgerald-Gustafson K.M., Fu V.L., Drover J.R., et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010, 91:848-859.
38. Dunstan J.A., Simmer K., Dixon G., Prescott S.L. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child 2008, 93:F45-F50.
39. Smithers L.G., Gibson R.A., Makrides M. Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. Am J Clin Nutr 2011, 93:1293-1299.
40. van Goor S.A., Janneke Dijck-Brouwer D.A., Erwich J.J.H.M., Schaafsma A., Hadders-Algra M. The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. Prostaglandins Leukot Essent Fatty Acids 2011, 84:139-146.
41. Willatts P., Forsyth S., Agostoni C., Casaer P., Riva E., Boehm G. Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood. Am J Clin Nutr 2013, 98:536S-542S.
42. Janssen C.I.F., Kiliaan A.J. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 2014, 53:1-17.
43. Birch E.E., Garfield S., Castaneda Y., Hughbanks-Wheaton D., Uauy R., Hoffman D. Visual acuity and cognitive outcomes at 4years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 2007, 83:279-284.
44. Birch E.E., Garfield S., Hoffman D.R., Uauy R., Birch D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000, 42:174-181.
45. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
46. Hoffman D.R., Birch E.E., Castaneda Y.S., Fawcett S.L., Wheaton D.H., Birch D.G., et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6months: a randomized clinical trial. J Pediatr 2003, 142:669-677.
47. Innis S.M., Friesen R.W. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 2008, 87:548-557.
48. Jensen C.L., Voigt R.G., Prager T.C., Zou Y.L., Fraley J.K., Rozelle J.C., et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 2005, 82:125-132.
49. Judge M.P., Harel O., Lammi-Keefe C.J. A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 2007, 42:117-122.
50. Judge M.P., Harel O., Lammi-Keefe C.J. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr 2007, 85:1572-1577.
51. Wurtman R.J. Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism 2008, 57(Suppl 2):S6-S10.
52. Bouwstra H., Dijck-Brouwer D.J., Decsi T., Boehm G., Boersma E.R., Muskiet F.A., et al. Relationship between umbilical cord essential fatty acid content and the quality of general movements of healthy term infants at 3months. Pediatr Res 2006, 59:717-722.
53. Fewtrell M.S., Morley R., Abbott R.A., Singhal A., Isaacs E.B., Stephenson T., et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002, 110:73-82.
54. Firmansyah A., Dwipoerwantoro P.G., Kadim M., Alatas S., Conus N., Lestarina L., et al. Improved growth of toddlers fed a milk containing synbiotics. Asia Pac J Clin Nutr 2011, 20:69-76.
55. Lauritzen L., Jorgensen M.H., Olsen S.F., Straarup E.M., Michaelsen K.F. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr Dev 2005, 45:535-547.
56. Lucas A., Stafford M., Morley R., Abbott R., Stephenson T., MacFadyen U., et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial. Lancet 1999, 354:1948-1954.
57. Malcolm C.A., McCulloch D.L., Montgomery C., Shepherd A., Weaver L.T. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child 2003, 88:F383-F390.
58. Niculescu M.D., Lupu D.S., Craciunescu C.N. Maternal alpha-linolenic acid availability during gestation and lactation alters the postnatal hippocampal development in the mouse offspring. Int J Dev Neurosci 2011, 29:795-802.
59. Carrié I., Guesnet P., Bourre J.M., Frances H. Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in mice. Br J Nutr 2000, 83:439-447.
60. Coluccia A., Borracci P., Renna G., Giustino A., Latronico T., Riccio P., et al. Developmental omega-3 supplementation improves motor skills in juvenile-adult rats. Int J Dev Neurosci 2009, 27:599-605.
61. Maekawa M., Takashima N., Matsumata M., Ikegami S., Kontani M., Hara Y., et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 2009, 4:e5085.
62. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
63. Fedorova I., Hussein N., Baumann M.H., Di Martino C., Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci 2009, 123:196-205.
64. Greiner R.S., Catalan J.N., Moriguchi T., Salem N. Docosapentaenoic acid does not completely replace DHA in n-3 FA-deficient rats during early development. Lipids 2003, 38:431-435.
65. Streijger F., Oerlemans F., Ellenbroek B.A., Jost C.R., Wieringa B., Van der Zee C.E. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res 2005, 157:219-234.
66. Hooijmans C.R., Van der Zee C.E., Dederen P.J., Brouwer K.M., Reijmer Y.D., van Groen T., et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis 2009, 33:482-498.
67. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993, 29:804-811.
68. Mulder M., Koopmans G., Wassink G., Al Mansouri G., Simard M.L., Havekes L.M., et al. LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus. Neurosci Res 2007, 59:251-256.
69. Rutten B.P., Van der Kolk N.M., Schafer S., van Zandvoort M.A., Bayer T.A., Steinbusch H.W., et al. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am J Pathol 2005, 167:161-173.
70. Zhou Y., Nijland M., Miller M., Ford S., Nathanielsz P.W., Brenna J.T. The influence of maternal early to mid-gestation nutrient restriction on long chain polyunsaturated fatty acids in fetal sheep. Lipids 2008, 43:525-531.
71. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
72. Carrié I., Clement M., de Javel D., Frances H., Bourre J.M. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J Lipid Res 2000, 41:473-480.
73. Enslen M., Milon H., Malnoe A. Effect of low intake of n-3 fatty acids during development on brain phospholipid fatty acid composition and exploratory behavior in rats. Lipids 1991, 26:203-208.
74. Nakashima Y., Yuasa S., Hukamizu Y., Okuyama H., Ohhara T., Kameyama T., et al. Effect of a high linoleate and a high alpha-linolenate diet on general behavior and drug sensitivity in mice. J Lipid Res 1993, 34:239-247.
75. O'Leary T.P., Gunn R.K., Brown R.E. What are we measuring when we test strain differences in anxiety in mice?. Behav Genet 2013, 43:34-50.
76. Geyer M.A., Dulawa S.C. Assessment of murine startle reactivity, prepulse inhibition, and habituation 2001, John Wiley & Sons, Inc., Hoboken, NJ.
77. Haubner L., Sullivan J., Ashmeade T., Saste M., Wiener D., Carver J. The effects of maternal dietary docosahexaenoic acid intake on rat pup myelin and the auditory startle response. Dev Neurosci 2007, 29:460-467.
78. Saste M.D., Carver J.D., Stockard J.E., Benford V.J., Chen L.T., Phelps C.P. Maternal diet fatty acid composition affects neurodevelopment in rat pups. J Nutr 1998, 128:740-743.
79. Bearzatto B., Servais L., Cheron G., Schiffmann S.N. Age dependence of strain determinant on mice motor coordination. Brain Res 2005, 1039:37-42.
80. Moriguchi T., Greiner R.S., Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000, 75:2563-2573.
81. Kavraal S., Oncu S.K., Bitiktas S., Artis A.S., Dolu N., Gunes T., et al. Maternal intake of omega-3 essential fatty acids improves long term potentiation in the dentate gyrus and Morris water maze performance in rats. Brain Res 2012, 1482:32-39.
82. Puri B.K., Koepp M.J., Holmes J., Hamilton G., Yuen A.W. A 31-phosphorus neurospectroscopy study of omega-3 long-chain polyunsaturated fatty acid intervention with eicosapentaenoic acid and docosahexaenoic acid in patients with chronic refractory epilepsy. Prostaglandins Leukot Essent Fatty Acids 2007, 77:105-107.
83. Pearce J.M., Komoroski R.A., Mrak R.E. Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy. Magn Reson Med 2009, 61:28-34.
84. McNamara R.K., Jandacek R., Tso P., Weber W., Chu W.J., Strakowski S.M., et al. Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS study. Nutr Neurosci 2013, 16:183-190.
85. Berger G.E., Wood S.J., Wellard R.M., Proffitt T.M., McConchie M., Amminger G.P., et al. Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 2008, 33:2467-2473.
86. Crupi R., Cambiaghi M., Deckelbaum R., Hansen I., Mindes J., Spina E., et al. n-3 Fatty acids prevent impairment of neurogenesis and synaptic plasticity in B-cell activating factor (BAFF) transgenic mice. Prev Med 2012, (54 Suppl):S103-S108.
87. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80:85-91.
88. Labrousse V.F., Nadjar A., Joffre C., Costes L., Aubert A., Gregoire S., et al. Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS One 2012, 7:e36861.